Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease
Clinical trial NCT02641054 · COMPLETED
Trial details
- NCT number
- NCT02641054
- Sponsor
- CleveXel Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.